Cite
Shearer J, Lynch TR, Chamba R, et al. Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. BJPsych Open. 2019;5(5):e64doi: 10.1192/bjo.2019.57.
Shearer, J., Lynch, T. R., Chamba, R., Clarke, S., Hempel, R. J., Kingdon, D. G., O'Mahen, H., Remington, B., Rushbrook, S. C., Russell, I. T., Stanton, M., Swales, M., Watkins, A., Whalley, B., & Byford, S. (2019). Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. BJPsych open, 5(5), e64. https://doi.org/10.1192/bjo.2019.57
Shearer, James, et al. "Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial." BJPsych open vol. 5,5 (2019): e64. doi: https://doi.org/10.1192/bjo.2019.57
Shearer J, Lynch TR, Chamba R, Clarke S, Hempel RJ, Kingdon DG, O'Mahen H, Remington B, Rushbrook SC, Russell IT, Stanton M, Swales M, Watkins A, Whalley B, Byford S. Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. BJPsych Open. 2019 Sep;5(5):e64. doi: 10.1192/bjo.2019.57. PMID: 31352916; PMCID: PMC6669879.
Copy
Download .nbib